Torrent Pharma

    TORNTPHARM
    Pharma
    ₹4965.50
    price as of 11/9/2026, 5:45:23 pm

    Market cap ₹1.89 L Cr

    P/E
    79.31
    Day range
    ₹4,894.00 – ₹4,988.00
    52-week range
    ₹3,480.60 – ₹5,250.00
    Volume
    2.63 L
    Open
    ₹4,929.00
    Prev close
    ₹4,930.00
    Promoters pledged 0.7% of their shares
    52-week range, adjusted for splits and bonuses
    ₹3,480.6₹5,250
    14 Oct 20253 Aug 2026
    Index membership & F&O
    NIFTY NEXT 50NIFTY 100NIFTY 200NIFTY 500NIFTY HEALTHCARENIFTY PHARMAF&O lot 125

    Price history

    6M change +12.06%RSI (14) 52.2 NeutralSMA 20 · 50 overlaid

    Price & delivery on the exchange

    NSE bhavcopy to 11 Sept 2026 · delivery 58.9% today vs 56.0% average · BSE close ₹4,975

    1 Apr23 Apr15 May5 Jun24 Jun15 Jul3 Aug21 Aug11 Sept₹3,850₹4,200₹4,550₹4,900₹5,2500%25%50%75%100%
    • Delivery
    • NSE close
    • BSE close

    High delivery with a rising price suggests buyers holding rather than trading the move.

    Futures & options

    NSE F&O close, 11 Sept 2026 · options expiring 29 Sept 2026

    Short covering
    Near-month future
    ₹4,969.5
    Change
    +0.72%
    Basis over spot
    +₹3.97
    Futures OI (shares)
    26.8 L
    OI change
    -0.87%
    Put-call ratio
    0.54
    Max pain
    ₹4,900
    Resistance (call OI)
    ₹5,000
    Support (put OI)
    ₹4,900
    Lot size
    125

    Open interest by strike

    Calls open above (resistance) and puts below (support), in shares

    4200440045004600470048004900500051005200530054005500560057005800040,00080,0001.2 L1.6 Lspot
    • Call OI
    • Put OI

    Futures open interest and price

    Near-month future, day by day since collection began

    The daily history builds from each close.

    Key metrics

    P/E (TTM)
    78.7
    EPS (TTM)
    ₹62.60
    ROE (FY26)
    26.8%
    ROCE (latest year)
    15%
    Dividend yield
    0.77%

    Charts & trends

    From company filings. Amounts in ₹ crore.

    Revenue 3Y CAGR
    +13.3%
    Profit 3Y CAGR
    +19.8%
    Revenue YoY (Jun 2026)
    +54.8%
    Profit YoY (Jun 2026)
    +3.3%
    Operating margin
    34.0%
    Net margin
    11.5%

    Revenue, profit & margin - quarterly

    Bars in ₹ crore (a loss shows red); line is operating margin

    Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Jun 20260 Cr1.5K Cr3.0K Cr4.5K Cr6.0K Cr0%9%18%27%36%
    • Revenue
    • Net profit
    • Operating margin

    Who owns the company

    Shareholding as of Jul 2026

    • Promoter
    • FII
    • DII
    • Public
    • Government

    Cash flows

    Where cash came from and went, by fiscal year (₹ crore)

    Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026-13.0KCr-6.5K Cr0 Cr6.5K Cr13.0K Cr
    • Operating
    • Investing
    • Financing
    • Free cash flow

    Return on equity

    Net profit over shareholders' equity, by fiscal year

    FY17FY18FY19FY20FY21FY22FY23FY24FY25FY260%7%14%21%28%15%

    Equity vs debt

    Shareholders' equity against borrowings (₹ crore); line is debt-to-equity

    Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 20260 Cr4.0K Cr8.0K Cr12.0K Cr16.0K Cr0.0x0.5x0.9x1.4x1.8x
    • Equity
    • Debt
    • Debt / equity

    Financial statements

    ₹ Crore
    Quarterly results, oldest period first, figures in rupees crore
    Line itemSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
    Sales2,6602,7322,7452,8592,8892,8092,9593,1783,3023,3034,1974,921
    Expenses1,8351,8631,8621,9551,9501,8951,9952,1462,2192,2152,8413,257
    Operating Profit8258698839049399149641,0321,0831,0881,3561,664
    OPM %31%32%32%32%32%33%33%32%33%33%32%34%
    Other Income26553124-1633-42-37-40-23-83-33
    Interest91808075645756564845236305
    Depreciation201213203197198199201201204206508593
    Profit before tax559631631656661691665738791814529733
    Tax %31%30%29%30%31%27%25%26%25%22%31%23%
    Net Profit386443449457453503498548591635364566
    EPS in Rs₹11.41₹13.09₹13.27₹13.50₹13.38₹14.86₹14.71₹16.19₹17.46₹18.76₹10.76₹16.72

    From company filings, updated 11 Sept 2026. Consolidated figures where the company reports them.Information only, not investment advice.

    Strengths, risks & growth

    Torrent Pharmaceuticals Ltd is one of the leading Indian Pharmaceutical Company engaged in research, development, manufacturing and marketing of generic pharmaceutical formulations. [1] It is the flagship company of Torrent Group which also has presence in power and city gas distribution businesses. [2]

    Strengths

    • Company is expected to give good quarter
    • Company has a good return on equity (ROE) track record: 3 Years ROE 26.2%
    • Company has been maintaining a healthy dividend payout of 57.8%

    Risks

    • Stock is trading at 20.1 times its book value
    • Promoter holding has decreased over last quarter: -7.53%
    • The company has delivered a poor sales growth of 11.8% over past five years.
    • Company might be capitalizing the interest cost

    Compounded Sales Growth

    10 Years
    +8%
    5 Years
    +12%
    3 Years
    +13%
    TTM
    +33%

    Compounded Profit Growth

    10 Years
    +2%
    5 Years
    +12%
    3 Years
    +22%
    TTM
    +10%

    Stock Price CAGR

    10 Years
    +20%
    5 Years
    +26%
    3 Years
    +39%
    1 Year
    +39%

    Return on Equity

    10 Years
    +22%
    5 Years
    +24%
    3 Years
    +26%
    Last Year
    +27%

    Strengths and risks are a machine-generated checklist, not advice; growth is compounded annually over each period.

    Shareholding pattern

    Percentage of shares held by each category at each quarter end
    HolderDec 2025Mar 2026Jun 2026Jul 2026Change
    Promoter68.31%68.31%68.31%60.78%-7.53 pp
    FII16.13%16.18%15.44%17.97%+2.53 pp
    DII9.05%8.96%9.73%12.77%+3.04 pp
    Government0.10%0.00%0.10%0.09%-0.01 pp
    Public6.41%6.55%6.42%8.39%+1.97 pp

    Filed with NSE for Jul 2026: promoters 60.78%, public 39.22% · XBRL filing

    Analysts & fund holdings

    82%
    82% recommend buy
    28 analysts cover the stock
    Valuation vs Pharmaceuticals
    P/E79.3 vs 46.4
    Sector P/B5.84
    Beta0.62

    Who holds the shares, quarter by quarter

    Mutual funds 8.27% (+3.33 pp)
    Jun 25
    Sept 25
    Dec 25
    Mar 26
    Jun 26
    Jul 26
    • Promoters60.8%
    • Foreign institutions18.0%
    • Mutual funds8.3%
    • Insurance2.0%
    • Other domestic institutions2.6%
    • Retail4.4%
    • Others4.0%
    Mutual funds holding the most
    Fund% of company% of fund3-month change
    HDFC Large Cap Fund0.86%4.04%+0.27 pp
    Kotak Mid Cap Fund0.51%1.38%+1.38 pp
    Axis Small Cap Fund0.39%2.39%+2.39 pp
    Axis Large Cap Fund0.21%1.26%+0.21 pp
    UTI Flexi Cap Fund0.19%1.43%+0.03 pp

    Scorecard

    Performance
    Avg
    Valuation
    High
    Growth
    Avg
    Profitability
    High
    Entry point
    Good
    Red flags
    Low

    Analyst coverage, holdings and scorecard from market data; not a recommendation by Parasram India.

    Corporate actions

    • dividend
      ₹9.00

      Dividend - Rs 9 Per Share

      29 May 2026
      ex-date
    • dividend
      ₹29.00

      Interim Dividend - Rs 29 Per Share

      18 Feb 2026
      ex-date
    • dividend
      ₹6.00

      Dividend - Rs 6 Per Share

      20 Jun 2025
      ex-date
    • dividend
      ₹26.00

      Interim Dividend - Rs 26 Per Sh

      31 Jan 2025
      ex-date
    • dividend
      ₹6.00

      Dividend - Rs 6 Per Share

      21 Jun 2024
      ex-date
    • dividend
      ₹22.00

      Interim Dividend - Rs 22 Per Share

      12 Feb 2024
      ex-date
    • dividend
      ₹8.00

      Dividend - Rs 8 Per Share

      23 Jun 2023
      ex-date
    • dividend
      ₹14.00

      Interim Dividend - Rs 14 Per Share

      3 Feb 2023
      ex-date
    • bonus
      Not available — not reported in this filing

      Bonus 1:1

      8 Jul 2022
      ex-date
    • dividend
      ₹25.00

      Interim Dividend - Rs 25 Per Share

      2 Feb 2022
      ex-date
    • dividend
      ₹15.00

      Dividend - Rs 15 Per Share

      17 Jun 2021
      ex-date
    • dividend
      ₹20.00

      Interim Dividend - Rs 20 Per Share

      15 Feb 2021
      ex-date
    • dividend
      ₹17.00

      Interim Dividend - Rs 17 Per Share Special Dividend - Rs 15 Per Share

      18 Mar 2020
      ex-date
    • dividend
      ₹4.00

      Dividend Rs 4 Per Share

      13 Jun 2019
      ex-date
    • dividend
      ₹13.00

      Interim Dividend - Rs 13 Per Share

      6 Feb 2019
      ex-date
    • dividend
      ₹5.00

      Dividend- Rs 5 Per Share

      18 Jun 2018
      ex-date
    • dividend
      ₹9.00

      Interim Dividend Rs 9/- Per Share (Purpose Revised)

      15 Feb 2018
      ex-date
    • dividend
      ₹4.00

      Dividend - Rs 4/- Per Share

      19 Jun 2017
      ex-date
    • dividend
      ₹10.00

      Interim Dividend Rs 10/- Per Share (Purpose Revised)

      10 Feb 2017
      ex-date
    • dividend
      ₹15.00

      Interim Dividend - Rs 15/- Per Share (Purpose Revised)

      16 Mar 2016
      ex-date

    Company announcements

    Company Update
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    Intimation of Schedule of Investor Meets

    Company Update
    Announcement under Regulation 30 (LODR)-Newspaper Publication

    Newspaper advertisement in respect of special window for transfer and dematerialisation of physical shares

    AGM/EGM
    Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot

    Outcome of Postal Ballot

    AGM/EGM
    Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

    Scrutinizer's Report on the Postal Ballot

    Company Update
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    Intimation of Schedule of Investors Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

    Company Update
    Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - ESG Rating

    ESG Rating

    Company Update
    Announcement under Regulation 30 (LODR)-Newspaper Publication

    Newspaper Advertisement for completion of dispatch of Postal Ballot Notice

    AGM/EGM
    Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

    Notice of Postal Ballot

    Company Update
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    Transcript of Conference call with Analysts / Investors on Financial Results for the quarter ended 30th June, 2026

    Company Update
    Announcement under Regulation 30 (LODR)-Cessation

    Intimation of Cessation of Director of the Company

    Company Update
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    Recording Link of Analyst call - Q1 Results

    Company Update
    Announcement under Regulation 30 (LODR)-Change in Management

    Change in Senior Management Personnel

    Board Meeting
    Board Meeting Outcome for Outcome Of Board Meeting Dated 30-Jul-26

    Outcome of Board Meeting dated 30-Jul-26

    Result
    Results For Quarter Ended 30-Jun-26

    Results for quarter ended 30-Jun-26

    Company Update
    Announcement under Regulation 30 (LODR)-Change in Management

    Appointment of Shanti Ekambaram as an Independent Director of the Company

    Filed with BSE (scrip 500420); the last 45 days. Documents open at bseindia.com.

    Documents

    Annual reports

    Earnings calls

    Credit ratings

    Documents open at BSE or the rating agency that issued them.

    Sourced from the company's NSE XBRL filing dated 24 Jan 2025 (unaudited). View the source filing. Figures are as filed and are not investment advice.